Unter den Marken unserer mehr als 25 Partner sticht TargetMol hervor
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Endet am 31. Dez.( 8 verbleibende Tage )
HDAC6-IN-14
HDAC6-IN-14, an inhibitor of HDAC6 (HDAC), exhibits high selectivity with an IC50 value of 42 nM, demonstrating over 100-fold selectivity compared to HDAC1,Formel:C24H30FN3O4Farbe und Form:SolidMolekulargewicht:443.51MtInhA-IN-1
MtInhA-IN-1: an oral selective MtInhA inhibitor, IC50 0.23 μM, effective against M. tuberculosis with MIC 0.4 μM.Formel:C21H22BrN3Farbe und Form:SolidMolekulargewicht:396.32TRK II-IN-1
CAS:<p>TRK II-IN-1: potent type II TRK inhibitor; IC50s: TRKA (3.3 nM), TRKB (6.4 nM), TRKC (4.3 nM), TRKA G667C (9.4 nM); also targets FLT3, RET, VEGFR2.</p>Formel:C29H31F3N8OReinheit:98%Farbe und Form:SolidMolekulargewicht:564.6NLRP3-IN-12
NLRP3-IN-12 inhibits NLRP3 inflammasome, curbing IL-1β release with 0.45 μM IC50, for inflammatory bowel disease research.Formel:C27H32ClNO7Farbe und Form:SolidMolekulargewicht:518STAT3-IN-15
STAT3-IN-15: Potent, oral STAT3 inhibitor for IPF, blocks STAT3 phosphorylation, cell migration, and EMT.Formel:C20H17F3N2O3SFarbe und Form:SolidMolekulargewicht:422.42hCA IX-IN-2
hCA IX-IN-2 is a highly potent and selective inhibitor of hCA IX, exhibiting an inhibition constant (K I) value of 32.1 nM and demonstrating anti-proliferativeFormel:C23H24N2O4STeFarbe und Form:SolidMolekulargewicht:552.11HSP90-IN-18
HSP90-IN-18 inhibits Hsp90 with 0.39 μM IC50, useful for viral, neurodegenerative, and inflammatory research.Formel:C25H33FO3Farbe und Form:SolidMolekulargewicht:400.53HSP90-IN-19
CAS:HSP90-IN-19: potent Hsp90 inhibitor, IC50 = 0.27 μM, used in research on viral diseases, neurodegeneration, inflammation.Formel:C29H38O7Reinheit:98%Farbe und Form:SolidMolekulargewicht:498.61CYP1B1-IN-3
CAS:CYP1B1-IN-3: strong CYP1B1 inhibitor (IC50: 6.6 nM); weak on CYP1A1/CYP1A2; hinders cell migration, invasion; blocks P-gp, AKT/ERK, FAK/SRC, EMT.Formel:C20H16FN3O2S2Farbe und Form:SolidMolekulargewicht:413.49DNQX
CAS:<p>DNQX (FG 9041) is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 μM for AMPA and kainate receptors, respectively)</p>Formel:C8H4N4O6Reinheit:97.27% - 99.1%Farbe und Form:Off-White Powder With A Yellow TingeMolekulargewicht:252.14CYP1B1-IN-4
CAS:<p>CYP1B1-IN-4: 2,4-diarylthiazole, selective CYP1B1 inhibitor (IC50=0.2 nM), low cytotoxicity, stable in liver microsomes.</p>Formel:C18H14N2O2SReinheit:98.74%Farbe und Form:SolidMolekulargewicht:322.38CYP1B1-IN-5
CAS:CYP1B1-IN-5: selective CYP1B1 inhibitor, IC50 = 4.7 nM, useful for metabolism disease research.Formel:C14H8INO2Reinheit:97.66%Farbe und Form:SolidMolekulargewicht:349.12HDAC6-IN-15
HDAC6-IN-15: selective HDAC6 inhibitor, IC50 of 38.2 nM, for cancer and neurodegenerative research.Formel:C25H28FFeN3O2Farbe und Form:SolidMolekulargewicht:477.35Urease-IN-4
<p>Urease-IN-4 inhibits urease (IC50: 1.64 µM), targets P. vulgaris (IC50: 15.27 µg/mL), and is low in cytotoxicity.</p>Formel:C16H20N2O3SFarbe und Form:SolidMolekulargewicht:320.41Urease-IN-5
Urease-IN-5: urease inhibitor, IC50 1.473 µM, low cytotoxicity, IC50 17.78 µg/mL on P. vulgaris.Formel:C16H20N2O3SFarbe und Form:SolidMolekulargewicht:320.41JQEZ5
CAS:JQEZ5 is an inhibitor of EZH2 lysine methyltransferase (IC50 = 11.1 nM).Formel:C30H38N8O2Reinheit:98.14% - ≥98%Farbe und Form:SolidMolekulargewicht:542.68KIF18A-IN-7
CAS:KIF18A-IN-7 is an orally active inhibitor targeting KIF18A, demonstrating potent inhibition with an IC50 value of 9.4 nM against the microtubule-dependentFormel:C27H35N3O5S2Farbe und Form:SoildMolekulargewicht:545.71Leritrelvir
CAS:<p>Dermatan sulphate sodium (Chondroitin sulfate B sodium salt) is a linear sulfated polysaccharide, a glycosaminoglycan component of important proteoglycans.</p>Formel:C31H44F3N5O6Reinheit:97.42%Farbe und Form:SolidMolekulargewicht:639.71Pomotrelvir
CAS:<p>Pomotrelvir (PBI-0451) is an oral SARS-CoV-2 3CL protease inhibitor with antiviral properties for COVID-19 research.</p>Formel:C23H26ClN5O3Farbe und Form:SolidMolekulargewicht:455.94BAY 2965501
CAS:BAY 2965501 is a potent and selective diacylglycerol kinase zeta (DGKζ) inhibitor that induces pERK activation.BAY 2965501 can be used in the study of cancer.Formel:C20H19FN4O3SReinheit:99.89%Farbe und Form:SolidMolekulargewicht:414.45Moiramide B
CAS:Moiramide B is an acetyl coenzyme A carboxylase inhibitor with antimicrobial activity, strongly inhibiting Gram-positive bacteria.Formel:C25H31N3O5Reinheit:98.53% - 99.90%Farbe und Form:SolidMolekulargewicht:453.53(S)-VQW-765
(S)-VQW-765, oral α7 nAChR partial agonist, may improve cognition in Alzheimer's and schizophrenia.Formel:C19H22N2OFarbe und Form:SolidMolekulargewicht:294.39Tiludronate
CAS:Tiludronate, an oral bisphosphonate, treats metabolic bone disorders and inhibits osteoclasts.Formel:C7H9ClO6P2SFarbe und Form:SolidMolekulargewicht:318.61Cloxacillin
CAS:Cloxacillin, a β-lactamase inhibitor, tackles S. aureus inflammation and has an IC50 of 0.04 µM.Formel:C19H18ClN3O5SFarbe und Form:SolidMolekulargewicht:435.88Acamprosate
CAS:Acamprosate, alcohol dependence treatment. Affordable Excellence: Reliable Quality You Can TrustFormel:C5H11NO4SReinheit:98.30%Farbe und Form:SolidMolekulargewicht:181.21Valorphin
CAS:Valorphin (Valorphin TFAsalt) has opioid analgesic activity, binds to rat mu-opioid receptor, with an IC50 of 14 nM.Formel:C44H61N9O11Reinheit:98%Farbe und Form:SolidMolekulargewicht:892.01Pralidoxime
CAS:Pralidoxime reactivates AChE blocked by nerve agents, aiding as an organophosphate poisoning antidote.Formel:C7H9N2OFarbe und Form:SolidMolekulargewicht:137.16Amakusamine
CAS:Amakusamine is an indole alkaloid from the sponge of Psammocinia sp. that inhibits RANKL-induced isolation of multinucleated osteoclast formation.Formel:C9H5Br2NO2Reinheit:98.37% - 98.42%Farbe und Form:SolidMolekulargewicht:318.95Rostratin A
CAS:Rostratin A, a disulfide from Exserohilum rostratum, is cytotoxic to HCT-116 cells with an IC50 of 8.5 μg/mL.Formel:C18H24N2O6S2Farbe und Form:SolidMolekulargewicht:428.52Rostratin B
CAS:Rostratin B, a cytotoxic disulfide, demonstrates in vitro cytotoxicity against human colon carcinoma (HCT-116), exhibiting an IC50 value of 1.9 μg/mL.Formel:C18H20N2O6S2Farbe und Form:SolidMolekulargewicht:424.49Rostratin C
CAS:Rostratin C, a cytotoxic disulfide, exhibits in vitro cytotoxicity against human colon carcinoma (HCT-116), demonstrating an IC50 value of 0.76 μg/mL.Formel:C20H24N2O8S2Farbe und Form:SolidMolekulargewicht:484.54Thielavin B
CAS:Thielavin B, from Thielavia terricola, inhibits prostaglandin E2 synthesis and reduces rat oedema.Formel:C31H34O10Farbe und Form:SolidMolekulargewicht:566.6Isodispar B
CAS:Isodispar B: an anticancer drug, halts many cancer types' growth, triggers cell death.Formel:C20H18O5Farbe und Form:SolidMolekulargewicht:338.35Mammea A/BA
CAS:Mammea A/BA combats T. cruzi by causing mitochondrial damage, ROS, DNA fragmentation, and vacuolization, leading to cell death. Useful for Chagas research.Formel:C25H26O5Farbe und Form:SolidMolekulargewicht:406.47Kurzipene D
CAS:Kurzipene D: anticancer, induces apoptosis, halts HepG2 at S phase, anti-tumor in zebrafish, inhibits tumor growth and spread.Formel:C26H36O8Farbe und Form:SolidMolekulargewicht:476.56Vorasidenib
CAS:Vorasidenib (PVM/MA) is an inhibitor of mutant isocitrate dehydrogenase (IDH; IC50s = 31.9 and 31.7 nM for IDH1R132H and IDH2R140Q, respectively)Formel:C14H13ClF6N6Reinheit:98.28% - 99.57%Farbe und Form:SolidMolekulargewicht:414.74STAT3-IN-14
CAS:<p>STAT3-IN-14 is a STAT3 inhibitor and has STAT3 phosphorylation inhibitory activity. STAT3-IN-14 can directly bind to the hinge region of STAT3 .</p>Formel:C14H10O5Farbe und Form:SolidMolekulargewicht:258.23PTP1B-IN-20
PTP1B-IN-20: Selective PTP1B inhibitor, IC50=1.05μM; less effective on TCPTP (IC50=78μM), targets type 2 diabetes.Formel:C26H28O15Farbe und Form:SolidMolekulargewicht:580.49PTP1B-IN-21
PTP1B-IN-21 inhibits PTP1B (IC50=1.56μM) selectively over TCPTP, a type 2 diabetes target.Formel:C22H22O11Farbe und Form:SolidMolekulargewicht:462.4Phanginin A
CAS:Phanginin A, a natural product, activates SIK1 and inhibits gluconeogenesis in mouse primary hepatocytes, can be used in studies of type 2 diabetes.Formel:C21H28O5Reinheit:95.54%Farbe und Form:SolidMolekulargewicht:360.44BACE1-IN-10
CAS:<p>BACE1-IN-10 is a potent inhibitor of BACE1, demonstrating sub-micromolar activity against recombinant BACE1 (rBACE1) [1].</p>Formel:C33H49N5O8SReinheit:98%Farbe und Form:SolidMolekulargewicht:675.84Nomifensine
CAS:Nomifensine ((±)-Nomifensin) is a norepinephrine-dopamine reuptake inhibitor that prevents dopamine reuptake into synaptosomes.Formel:C16H18N2Reinheit:99.83% - ≥95%Farbe und Form:SolidMolekulargewicht:238.33(R)-V-0219
(R)-V-0219: GLP-1R PAM, orally active, triggers Ca++ flux in HEK-hGLP-1R cells.Formel:C20H25F3N4O2Farbe und Form:SolidMolekulargewicht:410.43(S)-V-0219
(S)-V-0219: oral, GLP-1R PAM, boosts calcium in hGLP-1R HEK cells, lowers glucose, curbs hunger in mice.Formel:C20H25F3N4O2Farbe und Form:SolidMolekulargewicht:410.43TES Sodium
CAS:TES sodium is an amphoteric ion buffer with an effective pH range of 6.8 to 8.2, commonly used in cell culture and enzyme studies.Formel:C6H15NNaO6SFarbe und Form:SolidMolekulargewicht:252.24Nipradolol
CAS:Nipradolol blocks alpha-1-adrenergic receptors, lowers IOP in rabbits, and reduces NA-induced muscle contraction and dog artery vasodilation.Formel:C15H22N2O6Farbe und Form:SolidMolekulargewicht:326.35BMS 310705
CAS:BMS 310705, an Epothilone B analog, targets ovarian/renal/bladder/lung cancer, inducing apoptosis via mitochondria.Formel:C27H42N2O6SFarbe und Form:SolidMolekulargewicht:522.70Talotrexin
CAS:Talotrexin (PT523), a nonpolyglutamatable antifolate analog of Aminopterin, inhibits DHFR and RFC, targeting tumor growth.Formel:C27H27N9O6Farbe und Form:SolidMolekulargewicht:573.56Mavodelpar
CAS:Mavodelpar (REN001), a PPARδ agonist, may treat PMM and LC-FAOD by reducing renal damage.Formel:C31H29FNNaO5Farbe und Form:SolidMolekulargewicht:537.55TAS-103 dihydrochloride
CAS:<p>TAS-103 dihydrochloride (BMS-247615 dihydrochloride) is a novel anticancer agent targeting both topoisomerase (Topo) I and Topo II.</p>Formel:C20H21Cl2N3O2Reinheit:97.78%Farbe und Form:SolidMolekulargewicht:406.31EphB1-IN-1
CAS:EphB1-IN-1 is a potent inhibitor of EphB1, exhibiting IC50 values of 3.0 nM for EphB1 G703C, 15 nM for EphB1 T697G, and 220 nM for EphB1 WT.Formel:C16H12Cl2N4O2Farbe und Form:SolidMolekulargewicht:363.2NBI-921352
CAS:NBI-921352 (XEN901) is a potent NaV1.6 sodium channel inhibitor, effectively treating epilepsy without severe side effects.Formel:C22H25FN4O2S2Reinheit:98%Farbe und Form:SolidMolekulargewicht:460.59Udifitimod
CAS:Udifitimod (BMS-986166) is a potent, selective, and orally active modulator of the S1P1R receptor, showing potential for research in autoimmune diseases.Formel:C25H33NO2Farbe und Form:SolidMolekulargewicht:379.54Z-VRPR-FMK
CAS:Z-VRPR-FMK: irreversible MALT1 inhibitor, halts growth/invasion of diffused B-cell lymphoma by blocking NF-κB activation and MMP expression.Formel:C31H49FN10O6Farbe und Form:SolidMolekulargewicht:676.78Adhesamine
CAS:Adhesamine, a dumbbell molecule, enhances cell adhesion, growth, neuron differentiation, and survival via MAPK/FAK.Formel:C24H32Cl4N8O2S2Farbe und Form:SolidMolekulargewicht:670.51PNU-101603
CAS:<p>PNU-101603, a Sutezolid metabolite, effective against TB including drug-resistant strains, works solo or with SQ109.</p>Formel:C16H20FN3O4SFarbe und Form:SolidMolekulargewicht:369.41Z-LEVD-FMK
CAS:Z-LEVD-FMK is a caspase-4 inhibitor with anti-cancer activity, capable of eliminating LPS-induced GCLC protein degradation.Formel:C31H45FN4O10Farbe und Form:SolidMolekulargewicht:652.71SID-852843
CAS:SID-852843, WNV NS2B-NS3 protease inhibitor, IC50: 0.105 μM, useful in viral infection studies.Formel:C17H15N3O5SReinheit:99.59%Farbe und Form:SolidMolekulargewicht:373.38BACE2-IN-1
CAS:<p>BACE2-IN-1, a potent BACE2 inhibitor characterized by its exceptional selectivity and a Ki value of 1.6 nM, is utilized in the investigation of Type 2 Diabetes.</p>Formel:C36H38F3N3O3Farbe und Form:SolidMolekulargewicht:617.7Etbicyphat
CAS:Etbicyphat: potent GABA(A) antagonist, induces epileptiform activity, binds to GABA/benzodiazepine receptors.Formel:C6H11O4PFarbe und Form:SolidMolekulargewicht:178.12Paquinimod
CAS:Paquinimod (ABR 25757) is a S100A9 inhibitor preventing S100A9 binding to TLR-4.Formel:C21H22N2O3Reinheit:98.04% - 99.79%Farbe und Form:SolidMolekulargewicht:350.41ACT-606559
ACT-606559, a metabolite of ACT451840, is a novel chemical compound exhibiting antimalarial properties. It is utilized in malaria research.Formel:C47H52N6O3Farbe und Form:SolidMolekulargewicht:748.95EGFR-IN-25
CAS:EGFR-IN-25, an efficacious EGFR inhibitor, demonstrates IC50 values of 9 nM for BaF3 cells (EGFR DEL19/T790M/C797S) and 60 nM for A431 cells (WT), respectively.Formel:C34H43N9O2Farbe und Form:SolidMolekulargewicht:609.76EGFR-IN-21
CAS:EGFR-IN-21, a potent EGFR inhibitor, exhibits an IC50 of 0.38 nM, demonstrating significant antitumor activity.Formel:C36H44BrN10O2PFarbe und Form:SolidMolekulargewicht:759.68EGFR-IN-23
CAS:EGFR-IN-23, identified as compound 8 in WO2021244502A1, is a potent EGFR tyrosine kinase inhibitor (TKI) demonstrating an inhibitory concentration (IC50) of 8.Formel:C36H44BrN10O3PFarbe und Form:SolidMolekulargewicht:775.68EGFR-IN-28
CAS:EGFR-IN-28 is a potent EGFR inhibitor. EGFR-IN-28 has antitumor activity .Formel:C31H39BrN10O3SFarbe und Form:SolidMolekulargewicht:711.68EGFR-IN-29
CAS:EGFR-IN-29 is a potent EGFR inhibitor.Formel:C36H46BrN8O2PFarbe und Form:SolidMolekulargewicht:733.68RAD51-IN-4
CAS:RAD51-IN-4, a potent RAD51 inhibitor, may be useful in researching mitochondrial defect-related conditions.Formel:C31H34FN5O5S2Farbe und Form:SolidMolekulargewicht:639.76EGFR-IN-30
CAS:EGFR-IN-30 is an EGFR inhibitor (IC50: 1-10 nM, <1 nM WT/mutants) with potential in cancer research.Formel:C28H33BrN7O2PFarbe und Form:SolidMolekulargewicht:610.49JNK-1-IN-1
CAS:JNK-1-IN-1 is an inhibitor specifically targeting JNK-1, also exhibiting inhibition of MKK7 with an IC50 value of 7.8μM.Formel:C24H22N6SFarbe und Form:SolidMolekulargewicht:426.54Oxyphenisatin acetate
CAS:<p>Oxyphenisatin acetate inhibits the growth of the breast cancer cell lines MCF7, T47D, HS578T, and MDA-MB-468.</p>Formel:C24H19NO5Reinheit:98% - 99.35%Farbe und Form:SolidMolekulargewicht:401.41PI3Ka-IN-5
CAS:PI3Ka-IN-5 is a potent PI3Kα/mTOR inhibitor, with an IC 50 of 0.7 nM and 3.3 nM, respectively. PI3Ka-IN-5 can be used for the research of colorectal cancer .Formel:C30H35N9O5Farbe und Form:SolidMolekulargewicht:601.66IDO1-IN-17
CAS:IDO1-IN-17 (I-4) is an IDO1 inhibitor, with an IC 50 of 0.44 μM in hela cells .Formel:C28H32BrClFN5O2Farbe und Form:SolidMolekulargewicht:604.94STAT3-IN-7
CAS:STAT3-IN-7, an orally active aryl sulfonamido azetidine compound, serves as a STAT3 inhibitor with anticancer activities.Formel:C30H26F5N5O4SFarbe und Form:SolidMolekulargewicht:647.62(S)-HH2853
CAS:(S)-HH2853 is a potent EZH1/2 inhibitor, aromatic, <100 nM IC50 for EZH2_Y641F, promising for anti-tumor/autoimmune research.Formel:C31H36F3N7O3Reinheit:97.18% - 99.74%Farbe und Form:SolidMolekulargewicht:611.66(R)-HH2853
CAS:(R)-HH2853, a mutant EZH2 inhibitor, IC50 <100 nM for EZH2-Y641F, targets cancer/autoimmune diseases.Formel:C31H36F3N7O3Reinheit:97.53% - 98.85%Farbe und Form:SolidMolekulargewicht:611.66ROCK2-IN-5
ROCK2-IN-5, a compound blending fasudil, caffeic, and ferulic acids, shows promise for ALS research involving SOD1 mutations.Formel:C23H25N3O5SFarbe und Form:SolidMolekulargewicht:455.53PI3K-IN-28
CAS:PI3K-IN-28, a potent PI3K inhibitor with low toxicity in MCF-10a, has IC50 values of 5.8, 2.3, 7.9 μM and high selectivity index of 39.Formel:C26H16F9N3O3S2Farbe und Form:SolidMolekulargewicht:653.54AX20017
CAS:<p>AX20017 is a small-molecule protein kinase G (PknG) inhibitor(IC50 : 0.39 μM). It acts by blocking the proliferation of M. tuberculosis.</p>Formel:C13H16N2O2SReinheit:99.31%Farbe und Form:SolidMolekulargewicht:264.34MptpB-IN-1
CAS:MptpB-IN-1: orally active, potent MptpB inhibitor; reduces drug-resistant tuberculosis.Formel:C17H11Cl2NO4Farbe und Form:SolidMolekulargewicht:364.18FGFR4-IN-8
CAS:FGFR4-IN-8 is a selective, ATP-competitive FGFR4 inhibitor with IC50s as low as 0.25 nM, halting growth of Hep3B cells at 29 nM and showing in vivo efficacy.Formel:C32H34Cl2FN7O3Reinheit:98%Farbe und Form:SolidMolekulargewicht:654.56ThrRS-IN-3
ThrRS-IN-3: Potent inhibitor of Salmonella enterica ThrRS, IC50 = 19 nM, Kd = 34 nM, with antibacterial effects.Formel:C31H30Cl2N6O5Farbe und Form:SolidMolekulargewicht:637.51SMTIN-T140
CAS:SMTIN-T140: strong TRAP1 inhibitor, IC50=1.646μM, anticancer; disrupts mitochondria, boosts ROS, activates AMPK, shrinks PC3 tumors, no in vivo toxicity.Formel:C36H34BrClFN5OPReinheit:98%Farbe und Form:SolidMolekulargewicht:718.02C16-K-cBB1
C16-K-cBB1: potent, selective MRSA killer; MIC 1µg/mL, low hemolysis, works in 120 min at 12.5µg/mL.Formel:C33H58ClN5O5SFarbe und Form:SolidMolekulargewicht:672.36EGFR-IN-61
CAS:EGFR-IN-61 inhibits EGFR kinase (IC50: 42 nM L858R/T790M, 137 nM L858R/T790M/C797S, 743 nM WT) and slows A549 & H1975 cell growth (IC50: 2.14 & 1.82 μM).Formel:C33H37ClN8O3Reinheit:98%Farbe und Form:SolidMolekulargewicht:629.15STAT6-IN-1
CAS:STAT6-IN-1: STAT6 inhibitor, IC50=0.028 µM, targets SH2 domain, for allergy and cancer research.Formel:C33H37IN3O7PFarbe und Form:SolidMolekulargewicht:745.54Enclomiphene citrate
CAS:Enclomiphene citrate (trans-Clomiphene citrate) is a non-steroidal estrogen receptor antagonist,with antioestrogenic propertyFormel:C32H36ClNO8Reinheit:99.95%Farbe und Form:SolidMolekulargewicht:598.08Mebanazine
CAS:<p>Mebanazine, a potent monoamine oxidase (MAO) inhibitor, is utilized in depression research.</p>Formel:C8H12N2Farbe und Form:SolidMolekulargewicht:136.19DS69910557
DS69910557: potent hPTHR1 antagonist, IC50 0.08 μM, oral, for hyperparathyroidism & osteoporosis research.Formel:C32H33Cl2FN4O3Farbe und Form:SolidMolekulargewicht:611.53FGF22-IN-1
CAS:<p>FGF22-IN-1 is a CD4 N-terminal immunoglobulin variable region-like structural domain (CD4 D1) inhibitor that suppresses the immune response.</p>Formel:C14H11N3OSReinheit:99.18%Farbe und Form:SolidMolekulargewicht:269.32EZH2-IN-14
CAS:<p>EZH2-IN-14 selectively inhibits EZH2 at 12 nM IC50, has >200-fold specificity over EZH1, reducing H3K27me3 levels.</p>Formel:C31H39N7O2Farbe und Form:SolidMolekulargewicht:541.69USP7-IN-10
CAS:<p>USP7-IN-10 is a potent inhibitor of ubiquitin-specific protease 7 (USP7), exhibiting an inhibition concentration half-maximal (IC50) value of 13.39 nM.</p>Formel:C26H29ClN4O3SFarbe und Form:SolidMolekulargewicht:513.05MAT2A-IN-9
CAS:<p>MAT2A-IN-9, a 2-oxoquinazoline, inhibits MAT2A with antitumor effects on lymphomas and solid cancers.</p>Formel:C14H8ClF3N4OReinheit:99.17%Farbe und Form:SolidMolekulargewicht:340.69GSK1790627
CAS:GSK1790627, the N-deacetylated metabolite of Trametinib, represents an orally active MEK inhibitor that promotes autophagy and triggers apoptosis [1].Formel:C24H21FIN5O3Farbe und Form:SolidMolekulargewicht:573.36FLT3-IN-18
CAS:FLT3-IN-18: potent, selective FLT3 inhibitor, IC50 0.003 μM, induces apoptosis, G1 arrest, blocks FLT3/STAT5, potential in AML research.Formel:C26H36N8OFarbe und Form:SolidMolekulargewicht:476.62PHGDH-IN-3
CAS:PHGDH-IN-3, an oral PHGDH blocker with 2.8 μM IC50, may help in cancer research.Formel:C24H18FN3O4S2Reinheit:97.24% - 99.1%Farbe und Form:SolidMolekulargewicht:495.55FGFR3-IN-4
CAS:FGFR3-IN-4 is a selective inhibitor targeting FGFR3, demonstrating an IC50 value of under 50 nM.Formel:C26H24ClN7OFarbe und Form:SolidMolekulargewicht:485.97FGFR3-IN-5
CAS:<p>FGFR3-IN-5: potent, selective FGFR3 inhibitor. IC50: 3 nM FGFR3, 44 nM FGFR2, 289 nM FGFR1. For cancer research.</p>Formel:C24H24FN7O3Farbe und Form:SolidMolekulargewicht:477.49ACT-777991
CAS:ACT-777991: oral CXCR3 blocker, stable in microsomes/hepatocytes, inhibits T-cell migration to CXCL11.Formel:C20H20F6N8O2SFarbe und Form:SolidMolekulargewicht:550.48
